AstraZeneca appoints Joher Raniwalla as Vice-President

Bangalore, Dec 15 (UNI) AstraZeneca Pharma India today announced the appointment of Dr Joher Raniwalla as Vice-President, Medical and Regulatory of its pharma division here.

Dr Raniwalla joined Zeneca in 1996 and had extensive experience both as research physician and in general drug development, being medically responsible for the development of 'Seroquel', a drug used in the treatment of schizophrenia. He then worked in Japan from 2001-2004, where he took part in developing the Japan Clinical organisation and led the Japan Respiratory and Inflammation Therapy area, before being appointed as Medical Science Director in inflammation therapy in AZ Global R and D facility in the UK.

Company Pharma Managing Director Bhasker Iyer said in a statement here that Dr Raniwalla's international experience, both as research physician and in drug development, would be an asset in its Bangalore R and D facility.

UNI RS GD SKB1634